Boehringer Ingelheim unveils once-daily ProZinc for dogs
One injection a day can help to manage the clinical signs of canine diabetes for 18 to 24 hours.
Boehringer Ingelheim recently introduced once-daily ProZinc (protamine zinc recombinant human insulin) for the reduction of hyperglycemia and associated clinical signs in most canine diabetic patients.
“Once-daily dosing with ProZinc is a breakthrough for pet owners with diabetic dogs,” says Grant Beckett, BVSc, MRCVS, senior associate director of technical marketing at Boehringer Ingelheim, in a company release. “A single injection can provide consistent and reliable control of clinical signs for 18 to >24 hours in most canine patients.”
ProZinc, available by prescription only, was approved by the FDA for use in dogs early last year, making it the second veterinary-approved product available for managing canine diabetes.
“Not only is ProZinc more convenient for dog owners, but it reinforces veterinarians’ commitment to providing a better quality of life for their patients,” says Beckett in the release.
For more details about this product, go here.
For the latest on diabetes management, click here.
Proposed midlevel role poses unacceptable risks
October 30th 2024Proposals that would create a new midlevel practitioner (MLP) role raise serious concerns about the future of quality care for veterinary patients. Sometimes referred to as a veterinary professional associate (VPA), their duties would overlap those of a veterinarian and veterinary technician.
Read More
